Case ReportAn acute oral intoxication with haloperidol decanoate

Add time:09/02/2019    Source:sciencedirect.com

Haloperidol decanoate is a typical antipsychotic drug used as maintenance therapy for schizophrenia and mood disorders formulated as an ester for intramuscular injection. Cases of oral haloperidol decanoate intoxications have not been described in literature. In this report, we present for the first time a case of an oral ingestion of haloperidol decanoate of a young woman who presented to the emergency department following an intentional oral ingestion of 1 ampoule of haloperidol decanoate 100 mg. At presentation, she had a bilateral rest tremor of both hands and mild hypothermia. No other obvious signs of an intoxication were observed. She was treated with a single dose of activated charcoal and laxative and was admitted to the intensive care for rhythm monitoring and observation. During the night the QTc interval increased to 453 ms, but stayed within the normal range. Haloperidol plasma levels increased as well, but also stayed within therapeutic ranges. These findings indicate that treatment with oral activated charcoal was sufficient to prevent any serious events.

We also recommend Trading Suppliers and Manufacturers of potassium decanoate (cas 13040-18-1). Pls Click Website Link as below: cas 13040-18-1 suppliers

Prev:Synergistic extraction of zinc(II) with capric acid in the presence of pyridine
Next:The enthalpy of micellization of potassium decanoate (cas 13040-18-1) in solutions of H2O and D2O determined with microcalorimetry)